PMC:7556165 / 74070-74193 JSONTXT

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"2039","span":{"begin":66,"end":70},"obj":"Gene"},{"id":"2045","span":{"begin":35,"end":43},"obj":"Species"},{"id":"2051","span":{"begin":10,"end":34},"obj":"Disease"}],"attributes":[{"id":"A2039","pred":"pubann:denotes","subj":"2039","obj":"Gene:59272"},{"id":"A2045","pred":"pubann:denotes","subj":"2045","obj":"Tax:9606"},{"id":"A2051","pred":"pubann:denotes","subj":"2051","obj":"MESH:D006528"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T6496","span":{"begin":66,"end":70},"obj":"Protein"}],"attributes":[{"id":"A6496","pred":"uniprot_id","subj":"T6496","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T439","span":{"begin":10,"end":34},"obj":"Disease"}],"attributes":[{"id":"A439","pred":"mondo_id","subj":"T439","obj":"http://purl.obolibrary.org/obo/MONDO_0007256"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T80","span":{"begin":10,"end":34},"obj":"Phenotype"}],"attributes":[{"id":"A80","pred":"hp_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/HP_0001402"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T84","span":{"begin":10,"end":34},"obj":"Phenotype"}],"attributes":[{"id":"A84","pred":"hp_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/HP_0001402"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2039","span":{"begin":66,"end":70},"obj":"Gene"},{"id":"2045","span":{"begin":35,"end":43},"obj":"Species"},{"id":"2051","span":{"begin":10,"end":34},"obj":"Disease"}],"attributes":[{"id":"A2039","pred":"tao:has_database_id","subj":"2039","obj":"Gene:59272"},{"id":"A2045","pred":"tao:has_database_id","subj":"2045","obj":"Tax:9606"},{"id":"A2051","pred":"tao:has_database_id","subj":"2051","obj":"MESH:D006528"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" out that hepatocellular carcinoma patients with higher levels of ACE2 had longer survival times, suggesting a positive lin"}